Machine learning for predicting all-cause mortality of metabolic dysfunction-associated fatty liver disease: a longitudinal study based on NHANES
Background The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, th...
Uloženo v:
| Vydáno v: | BMC gastroenterology Ročník 25; číslo 1; s. 376 - 14 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
BioMed Central
15.05.2025
BioMed Central Ltd Springer Nature B.V BMC |
| Témata: | |
| ISSN: | 1471-230X, 1471-230X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background
The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals.
Methods
We included 3921 MAFLD individuals in NHANES III. After a median follow-up time of 310 months, 1815 (46.3%) deaths were recorded. The data (demographic, behavioral factors and laboratory indicators) were utilized to construct machine learning models (Coxnet, RSF, GBS) after feature selection. Time-dependent AUC, time-dependent brier and C-index were then evaluated the performance of models. We identified the top five factors that contributed significantly to all-cause mortality and further explore the association with all-cause mortality using RCS and Kaplan–Meier survival curves.
Results
Coxnet showed the best performance in short-term and long-term predictions with time-dependent AUC of 0.82 at 5 years and 0.88 at 25 years. Age, FORNS, waist circumstance, AAR, FLI were associated positively with all-cause mortality. Compared to the individuals who smoked more than 100 cigarettes, those below 100 had better survival outcome (
P
< 0.0001).
Conclusions
Machine learning has a promising application in predicting all-cause mortality in MAFLD individuals. Combined the results of interpretable machine learning and association analyses, we found risk factors which contributing to the all-cause mortality. These findings provide insights for community health practitioners to intervene in modifiable risk factors, thereby improving the survival and quality of life of MAFLD individuals. |
|---|---|
| AbstractList | The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals.BACKGROUNDThe mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals.We included 3921 MAFLD individuals in NHANES III. After a median follow-up time of 310 months, 1815 (46.3%) deaths were recorded. The data (demographic, behavioral factors and laboratory indicators) were utilized to construct machine learning models (Coxnet, RSF, GBS) after feature selection. Time-dependent AUC, time-dependent brier and C-index were then evaluated the performance of models. We identified the top five factors that contributed significantly to all-cause mortality and further explore the association with all-cause mortality using RCS and Kaplan-Meier survival curves.METHODSWe included 3921 MAFLD individuals in NHANES III. After a median follow-up time of 310 months, 1815 (46.3%) deaths were recorded. The data (demographic, behavioral factors and laboratory indicators) were utilized to construct machine learning models (Coxnet, RSF, GBS) after feature selection. Time-dependent AUC, time-dependent brier and C-index were then evaluated the performance of models. We identified the top five factors that contributed significantly to all-cause mortality and further explore the association with all-cause mortality using RCS and Kaplan-Meier survival curves.Coxnet showed the best performance in short-term and long-term predictions with time-dependent AUC of 0.82 at 5 years and 0.88 at 25 years. Age, FORNS, waist circumstance, AAR, FLI were associated positively with all-cause mortality. Compared to the individuals who smoked more than 100 cigarettes, those below 100 had better survival outcome (P < 0.0001).RESULTSCoxnet showed the best performance in short-term and long-term predictions with time-dependent AUC of 0.82 at 5 years and 0.88 at 25 years. Age, FORNS, waist circumstance, AAR, FLI were associated positively with all-cause mortality. Compared to the individuals who smoked more than 100 cigarettes, those below 100 had better survival outcome (P < 0.0001).Machine learning has a promising application in predicting all-cause mortality in MAFLD individuals. Combined the results of interpretable machine learning and association analyses, we found risk factors which contributing to the all-cause mortality. These findings provide insights for community health practitioners to intervene in modifiable risk factors, thereby improving the survival and quality of life of MAFLD individuals.CONCLUSIONSMachine learning has a promising application in predicting all-cause mortality in MAFLD individuals. Combined the results of interpretable machine learning and association analyses, we found risk factors which contributing to the all-cause mortality. These findings provide insights for community health practitioners to intervene in modifiable risk factors, thereby improving the survival and quality of life of MAFLD individuals. Background The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals. Methods We included 3921 MAFLD individuals in NHANES III. After a median follow-up time of 310 months, 1815 (46.3%) deaths were recorded. The data (demographic, behavioral factors and laboratory indicators) were utilized to construct machine learning models (Coxnet, RSF, GBS) after feature selection. Time-dependent AUC, time-dependent brier and C-index were then evaluated the performance of models. We identified the top five factors that contributed significantly to all-cause mortality and further explore the association with all-cause mortality using RCS and Kaplan-Meier survival curves. Results Coxnet showed the best performance in short-term and long-term predictions with time-dependent AUC of 0.82 at 5 years and 0.88 at 25 years. Age, FORNS, waist circumstance, AAR, FLI were associated positively with all-cause mortality. Compared to the individuals who smoked more than 100 cigarettes, those below 100 had better survival outcome (P < 0.0001). Conclusions Machine learning has a promising application in predicting all-cause mortality in MAFLD individuals. Combined the results of interpretable machine learning and association analyses, we found risk factors which contributing to the all-cause mortality. These findings provide insights for community health practitioners to intervene in modifiable risk factors, thereby improving the survival and quality of life of MAFLD individuals. Keywords: All-cause mortality, Machine learning, Metabolic dysfunction-associated fatty liver disease, Fatty liver BackgroundThe mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals.MethodsWe included 3921 MAFLD individuals in NHANES III. After a median follow-up time of 310 months, 1815 (46.3%) deaths were recorded. The data (demographic, behavioral factors and laboratory indicators) were utilized to construct machine learning models (Coxnet, RSF, GBS) after feature selection. Time-dependent AUC, time-dependent brier and C-index were then evaluated the performance of models. We identified the top five factors that contributed significantly to all-cause mortality and further explore the association with all-cause mortality using RCS and Kaplan–Meier survival curves.ResultsCoxnet showed the best performance in short-term and long-term predictions with time-dependent AUC of 0.82 at 5 years and 0.88 at 25 years. Age, FORNS, waist circumstance, AAR, FLI were associated positively with all-cause mortality. Compared to the individuals who smoked more than 100 cigarettes, those below 100 had better survival outcome (P < 0.0001).ConclusionsMachine learning has a promising application in predicting all-cause mortality in MAFLD individuals. Combined the results of interpretable machine learning and association analyses, we found risk factors which contributing to the all-cause mortality. These findings provide insights for community health practitioners to intervene in modifiable risk factors, thereby improving the survival and quality of life of MAFLD individuals. Background The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals. Methods We included 3921 MAFLD individuals in NHANES III. After a median follow-up time of 310 months, 1815 (46.3%) deaths were recorded. The data (demographic, behavioral factors and laboratory indicators) were utilized to construct machine learning models (Coxnet, RSF, GBS) after feature selection. Time-dependent AUC, time-dependent brier and C-index were then evaluated the performance of models. We identified the top five factors that contributed significantly to all-cause mortality and further explore the association with all-cause mortality using RCS and Kaplan–Meier survival curves. Results Coxnet showed the best performance in short-term and long-term predictions with time-dependent AUC of 0.82 at 5 years and 0.88 at 25 years. Age, FORNS, waist circumstance, AAR, FLI were associated positively with all-cause mortality. Compared to the individuals who smoked more than 100 cigarettes, those below 100 had better survival outcome ( P < 0.0001). Conclusions Machine learning has a promising application in predicting all-cause mortality in MAFLD individuals. Combined the results of interpretable machine learning and association analyses, we found risk factors which contributing to the all-cause mortality. These findings provide insights for community health practitioners to intervene in modifiable risk factors, thereby improving the survival and quality of life of MAFLD individuals. Abstract Background The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals. Methods We included 3921 MAFLD individuals in NHANES III. After a median follow-up time of 310 months, 1815 (46.3%) deaths were recorded. The data (demographic, behavioral factors and laboratory indicators) were utilized to construct machine learning models (Coxnet, RSF, GBS) after feature selection. Time-dependent AUC, time-dependent brier and C-index were then evaluated the performance of models. We identified the top five factors that contributed significantly to all-cause mortality and further explore the association with all-cause mortality using RCS and Kaplan–Meier survival curves. Results Coxnet showed the best performance in short-term and long-term predictions with time-dependent AUC of 0.82 at 5 years and 0.88 at 25 years. Age, FORNS, waist circumstance, AAR, FLI were associated positively with all-cause mortality. Compared to the individuals who smoked more than 100 cigarettes, those below 100 had better survival outcome (P < 0.0001). Conclusions Machine learning has a promising application in predicting all-cause mortality in MAFLD individuals. Combined the results of interpretable machine learning and association analyses, we found risk factors which contributing to the all-cause mortality. These findings provide insights for community health practitioners to intervene in modifiable risk factors, thereby improving the survival and quality of life of MAFLD individuals. The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals. We included 3921 MAFLD individuals in NHANES III. After a median follow-up time of 310 months, 1815 (46.3%) deaths were recorded. The data (demographic, behavioral factors and laboratory indicators) were utilized to construct machine learning models (Coxnet, RSF, GBS) after feature selection. Time-dependent AUC, time-dependent brier and C-index were then evaluated the performance of models. We identified the top five factors that contributed significantly to all-cause mortality and further explore the association with all-cause mortality using RCS and Kaplan-Meier survival curves. Coxnet showed the best performance in short-term and long-term predictions with time-dependent AUC of 0.82 at 5 years and 0.88 at 25 years. Age, FORNS, waist circumstance, AAR, FLI were associated positively with all-cause mortality. Compared to the individuals who smoked more than 100 cigarettes, those below 100 had better survival outcome (P < 0.0001). Machine learning has a promising application in predicting all-cause mortality in MAFLD individuals. Combined the results of interpretable machine learning and association analyses, we found risk factors which contributing to the all-cause mortality. These findings provide insights for community health practitioners to intervene in modifiable risk factors, thereby improving the survival and quality of life of MAFLD individuals. The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors influencing it. While advanced machine learning algorithms are gaining recognition as effective tools for clinical prediction, their ability to predict all-cause mortality of MAFLD individuals remains uncertain. This study aimed to develop different machine learning models to predict all-cause mortality of MAFLD individuals, compare the predictive performance of these models, and identify the risk factors contributing all-cause mortality, which is crucial for management of MAFLD individuals. We included 3921 MAFLD individuals in NHANES III. After a median follow-up time of 310 months, 1815 (46.3%) deaths were recorded. The data (demographic, behavioral factors and laboratory indicators) were utilized to construct machine learning models (Coxnet, RSF, GBS) after feature selection. Time-dependent AUC, time-dependent brier and C-index were then evaluated the performance of models. We identified the top five factors that contributed significantly to all-cause mortality and further explore the association with all-cause mortality using RCS and Kaplan-Meier survival curves. Coxnet showed the best performance in short-term and long-term predictions with time-dependent AUC of 0.82 at 5 years and 0.88 at 25 years. Age, FORNS, waist circumstance, AAR, FLI were associated positively with all-cause mortality. Compared to the individuals who smoked more than 100 cigarettes, those below 100 had better survival outcome (P < 0.0001). Machine learning has a promising application in predicting all-cause mortality in MAFLD individuals. Combined the results of interpretable machine learning and association analyses, we found risk factors which contributing to the all-cause mortality. These findings provide insights for community health practitioners to intervene in modifiable risk factors, thereby improving the survival and quality of life of MAFLD individuals. |
| ArticleNumber | 376 |
| Audience | Academic |
| Author | Chen, Huihui Wang, Luqiao Sun, Wenguang Wang, Xueni |
| Author_xml | – sequence: 1 givenname: Xueni surname: Wang fullname: Wang, Xueni organization: Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, and Department of Big Data in Health Science School of Public Health, Zhejiang University School of Medicine, Zhejiang University – sequence: 2 givenname: Huihui surname: Chen fullname: Chen, Huihui organization: Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, and Department of Big Data in Health Science School of Public Health, Zhejiang University School of Medicine, Zhejiang University – sequence: 3 givenname: Luqiao surname: Wang fullname: Wang, Luqiao organization: Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, and Department of Big Data in Health Science School of Public Health, Zhejiang University School of Medicine, Zhejiang University – sequence: 4 givenname: Wenguang surname: Sun fullname: Sun, Wenguang email: wgsun@zju.edu.cn organization: Center for Data Science, Zhejiang University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40375096$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1vEzEQhleoiH7AH-CALHHhssXfu8stqgqtVMoBkLhZXnscHDl2sHeR8jP4xzhJaQEh5IM94-ed0djvaXMUU4SmeU7wOSG9fF0I7TvZYipazAYuW_6oOSG8Iy1l-MvRb-fj5rSUFcak6yl70hxzzDqBB3nS_HivzVcfAQXQOfq4RC5ltMlgvZl2oQ6hNXougNYpTzr4aYuSQ2uY9JiCN8hui5tjhVNsdSnJeD2BRU5PlQz-O2RkfQFd4A3SKKS49NNsfdQBlXrYorFeWZQiur1a3F5-fNo8djoUeHa3nzWf315-urhqbz68u75Y3LRGYDG1xDlHeipHzNxgLdGMS0IBpOkN6zTDnHV0H1tiOyowY1y4YRgHy0ZqgJ0114e6NumV2mS_1nmrkvZqn0h5qXSevAmgRmYHJixwTgW3go7SsoEKsN1owdKh1np1qLXJ6dsMZVJrXwyEoCOkuShGMe-4ZFhW9OVf6CrNub7GjiJSiPql7IFa6trfR5emrM2uqFr0HGPW97Kv1Pk_qLosrL2pZnG-5v8QvLhrPo9rsPdT__JDBegBMDmVksHdIwSrnenUwXSqmk7tTad4FbGDqFQ4LiE_jPQf1U9hadjr |
| Cites_doi | 10.1093/ageing/afab067 10.1093/bjs/znab237 10.1016/j.ecoenv.2023.115864 10.1038/s42003-023-05456-z 10.1111/liv.15849 10.1016/j.amjmed.2020.01.007 10.3389/fimmu.2023.1140755 10.1016/j.jhep.2021.05.037 10.1186/s12876-024-03471-w 10.1111/apt.17722 10.1136/svn-2017-000101 10.1016/j.ijmedinf.2024.105700 10.1186/s12889-024-19882-z 10.1186/s12933-024-02503-9 10.1186/s12889-025-21339-w 10.1007/s40618-025-02548-x 10.1016/j.ecl.2023.02.006 10.1016/j.aohep.2024.101528 10.4178/epih.e2024024 10.1186/s12940-024-01137-4 10.3390/cancers16061114 10.1038/s41598-024-79899-7 10.1053/j.gastro.2019.11.312 10.1038/s41598-024-59183-4 10.3390/jcm13041181 10.1038/s41598-024-65601-4 10.1016/j.cgh.2018.11.033 10.1136/bmjopen-2022-067203 10.1111/apt.16760 10.1038/s41598-024-78498-w 10.1016/j.compbiomed.2021.104813 10.1093/ndt/gfac316 10.3389/fendo.2024.1457869 10.1016/j.jhep.2021.07.035 10.1007/s12072-024-10671-9 10.1111/liv.15818 10.1111/liv.13408 10.1186/s12933-024-02287-y 10.1111/liv.16075 10.1056/NEJMra1814259 10.1016/j.jhep.2020.03.039 10.1002/hep.30864 10.3390/medicina58101348 10.2196/44417 10.3390/nu16132063 10.1038/s41598-024-63453-6 10.1016/j.metabol.2024.155999 10.1002/hep4.1534 10.1186/s12933-024-02354-4 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2025 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FR3 FYUFA GHDGH H94 K9. M0S M1P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 DOA |
| DOI | 10.1186/s12876-025-03946-4 |
| DatabaseName | SpringerOpen CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database Biotechnology and BioEngineering Abstracts ProQuest One Academic ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic DOAJ Directory of Open Access Journals (WRLC) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Statistics |
| EISSN | 1471-230X |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_b3d935de44254d52b6d3925ed7bded29 A840038868 40375096 10_1186_s12876_025_03946_4 |
| Genre | Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M~E O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7XB 8FD 8FK AZQEC COVID DWQXO FR3 H94 K9. M48 P64 PKEHL PQEST PQUKI 7X8 |
| ID | FETCH-LOGICAL-c505t-1fff1826b03f9dd1a34612ee6c8c37a3043722ee6cd1d72503345f99b9d3b2ce3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001489564200006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-230X |
| IngestDate | Fri Oct 03 12:53:32 EDT 2025 Fri Sep 05 16:44:32 EDT 2025 Sat Nov 29 14:27:09 EST 2025 Sat Nov 29 13:47:24 EST 2025 Sat Nov 29 10:29:10 EST 2025 Mon May 19 02:16:37 EDT 2025 Sat Nov 29 07:55:28 EST 2025 Sat Sep 06 07:35:39 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | All-cause mortality Fatty liver Metabolic dysfunction-associated fatty liver disease Machine learning |
| Language | English |
| License | 2025. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c505t-1fff1826b03f9dd1a34612ee6c8c37a3043722ee6cd1d72503345f99b9d3b2ce3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://link.springer.com/10.1186/s12876-025-03946-4 |
| PMID | 40375096 |
| PQID | 3216558763 |
| PQPubID | 44673 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_b3d935de44254d52b6d3925ed7bded29 proquest_miscellaneous_3204746306 proquest_journals_3216558763 gale_infotracmisc_A840038868 gale_infotracacademiconefile_A840038868 pubmed_primary_40375096 crossref_primary_10_1186_s12876_025_03946_4 springer_journals_10_1186_s12876_025_03946_4 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-05-15 |
| PublicationDateYYYYMMDD | 2025-05-15 |
| PublicationDate_xml | – month: 05 year: 2025 text: 2025-05-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC gastroenterology |
| PublicationTitleAbbrev | BMC Gastroenterol |
| PublicationTitleAlternate | BMC Gastroenterol |
| PublicationYear | 2025 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | 3946_CR36 ZM Younossi (3946_CR11) 2019; 17 W Liu (3946_CR32) 2024; 15 NTD Tran (3946_CR34) 2022; 38 H Zhou (3946_CR20) 2023; 14 J Fei (3946_CR16) 2017; 2 WC Cheng (3946_CR13) 2024; 46 S Duan (3946_CR44) 2024; 270 M Eslam (3946_CR4) 2020; 158 M Suárez (3946_CR28) 2024; 16 X Yang (3946_CR41) 2023; 25 X Guo (3946_CR18) 2025; 25 D Kim (3946_CR6) 2021; 75 J Deng (3946_CR21) 2024; 24 C Ning (3946_CR39) 2024; 110 C Bonfiglio (3946_CR25) 2024; 13 P Charatcharoenwitthaya (3946_CR12) 2024; 14 Y Zhang (3946_CR29) 2024; 23 P Golabi (3946_CR47) 2020; 4 F Åberg (3946_CR10) 2017; 37 L Magga (3946_CR37) 2022; 58 A Rajkomar (3946_CR17) 2019; 380 N Kapoor (3946_CR5) 2023; 52 B Njei (3946_CR22) 2024; 14 DN Rasmussen (3946_CR48) 2021; 75 K Wang (3946_CR19) 2021; 137 G Pennisi (3946_CR3) 2024; 44 CF do Nascimento (3946_CR33) 2021; 50 J Bortz (3946_CR38) 2023; 6 JTK Cheung (3946_CR24) 2023; 58 D Shamsutdinova (3946_CR45) 2024; 194 Y Zhu (3946_CR14) 2024; 44 R Fan (3946_CR23) 2024; 44 Y Huang (3946_CR49) 2024; 16 Y Min (3946_CR30) 2024; 23 M Decraecker (3946_CR31) 2022; 55 HC Tan (3946_CR35) 2024; 14 M Eslam (3946_CR2) 2020; 73 J Budd (3946_CR50) 2020; 133 F Åberg (3946_CR9) 2020; 71 SA Rahman (3946_CR40) 2021; 108 J Lin (3946_CR43) 2024; 14 SH Cho (3946_CR7) 2024; 18 H Zhang (3946_CR8) 2024; 160 X Ma (3946_CR1) 2024; 24 I Drozdov (3946_CR26) 2024; 29 RM Carrillo-Larco (3946_CR27) 2022; 12 L Luo (3946_CR15) 2024; 14 X Liu (3946_CR42) 2024; 23 SD Fansler (3946_CR46) 2024; 23 |
| References_xml | – volume: 50 start-page: 1692 issue: 5 year: 2021 ident: 3946_CR33 publication-title: Age Ageing doi: 10.1093/ageing/afab067 – volume: 108 start-page: 1341 issue: 11 year: 2021 ident: 3946_CR40 publication-title: Br J Surg doi: 10.1093/bjs/znab237 – volume: 270 start-page: 115864 year: 2024 ident: 3946_CR44 publication-title: Ecotoxicol Environ Saf doi: 10.1016/j.ecoenv.2023.115864 – volume: 6 start-page: 1089 issue: 1 year: 2023 ident: 3946_CR38 publication-title: Commun Biol doi: 10.1038/s42003-023-05456-z – volume: 44 start-page: 865 issue: 3 year: 2024 ident: 3946_CR14 publication-title: Liver Int doi: 10.1111/liv.15849 – volume: 133 start-page: 536 issue: 5 year: 2020 ident: 3946_CR50 publication-title: Am J Med doi: 10.1016/j.amjmed.2020.01.007 – volume: 14 start-page: 1140755 year: 2023 ident: 3946_CR20 publication-title: Front Immunol doi: 10.3389/fimmu.2023.1140755 – volume: 75 start-page: 1017 issue: 5 year: 2021 ident: 3946_CR48 publication-title: J Hepatol doi: 10.1016/j.jhep.2021.05.037 – volume: 24 start-page: 389 issue: 1 year: 2024 ident: 3946_CR1 publication-title: BMC Gastroenterol doi: 10.1186/s12876-024-03471-w – volume: 58 start-page: 1194 issue: 11–12 year: 2023 ident: 3946_CR24 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.17722 – volume: 2 start-page: 230 issue: 4 year: 2017 ident: 3946_CR16 publication-title: Stroke Vasc Neurol doi: 10.1136/svn-2017-000101 – volume: 194 start-page: 105700 year: 2024 ident: 3946_CR45 publication-title: Int J Med Inform doi: 10.1016/j.ijmedinf.2024.105700 – volume: 24 start-page: 2545 issue: 1 year: 2024 ident: 3946_CR21 publication-title: BMC Public Health doi: 10.1186/s12889-024-19882-z – volume: 23 start-page: 407 issue: 1 year: 2024 ident: 3946_CR42 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-024-02503-9 – volume: 25 start-page: 319 issue: 1 year: 2025 ident: 3946_CR18 publication-title: BMC Public Health doi: 10.1186/s12889-025-21339-w – ident: 3946_CR36 doi: 10.1007/s40618-025-02548-x – volume: 52 start-page: 469 issue: 3 year: 2023 ident: 3946_CR5 publication-title: Endocrinol Metab Clin North Am doi: 10.1016/j.ecl.2023.02.006 – volume: 29 start-page: 101528 issue: 5 year: 2024 ident: 3946_CR26 publication-title: Ann Hepatol doi: 10.1016/j.aohep.2024.101528 – volume: 46 start-page: e2024024 year: 2024 ident: 3946_CR13 publication-title: Epidemiol Health doi: 10.4178/epih.e2024024 – volume: 23 start-page: 96 issue: 1 year: 2024 ident: 3946_CR46 publication-title: Environ Health doi: 10.1186/s12940-024-01137-4 – volume: 16 start-page: 1114 issue: 6 year: 2024 ident: 3946_CR28 publication-title: Cancers (Basel) doi: 10.3390/cancers16061114 – volume: 14 start-page: 28240 issue: 1 year: 2024 ident: 3946_CR43 publication-title: Sci Rep doi: 10.1038/s41598-024-79899-7 – volume: 158 start-page: 1999 issue: 7 year: 2020 ident: 3946_CR4 publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.11.312 – volume: 14 start-page: 8589 issue: 1 year: 2024 ident: 3946_CR22 publication-title: Sci Rep doi: 10.1038/s41598-024-59183-4 – volume: 13 start-page: 1181 issue: 4 year: 2024 ident: 3946_CR25 publication-title: J Clin Med doi: 10.3390/jcm13041181 – volume: 14 start-page: 14639 issue: 1 year: 2024 ident: 3946_CR35 publication-title: Sci Rep doi: 10.1038/s41598-024-65601-4 – volume: 17 start-page: 1625 issue: 8 year: 2019 ident: 3946_CR11 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2018.11.033 – volume: 12 start-page: e067203 issue: 11 year: 2022 ident: 3946_CR27 publication-title: BMJ Open doi: 10.1136/bmjopen-2022-067203 – volume: 55 start-page: 580 issue: 5 year: 2022 ident: 3946_CR31 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.16760 – volume: 14 start-page: 26979 issue: 1 year: 2024 ident: 3946_CR15 publication-title: Sci Rep doi: 10.1038/s41598-024-78498-w – volume: 137 start-page: 104813 year: 2021 ident: 3946_CR19 publication-title: Comput Biol Med doi: 10.1016/j.compbiomed.2021.104813 – volume: 38 start-page: 1691 issue: 7 year: 2022 ident: 3946_CR34 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfac316 – volume: 15 start-page: 1457869 year: 2024 ident: 3946_CR32 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2024.1457869 – volume: 75 start-page: 1284 issue: 6 year: 2021 ident: 3946_CR6 publication-title: J Hepatol doi: 10.1016/j.jhep.2021.07.035 – volume: 18 start-page: 1168 issue: 4 year: 2024 ident: 3946_CR7 publication-title: Hepatol Int doi: 10.1007/s12072-024-10671-9 – volume: 44 start-page: 749 issue: 3 year: 2024 ident: 3946_CR23 publication-title: Liver Int doi: 10.1111/liv.15818 – volume: 37 start-page: 1373 issue: 9 year: 2017 ident: 3946_CR10 publication-title: Liver Int doi: 10.1111/liv.13408 – volume: 23 start-page: 188 issue: 1 year: 2024 ident: 3946_CR30 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-024-02287-y – volume: 44 start-page: 2939 issue: 11 year: 2024 ident: 3946_CR3 publication-title: Liver Int doi: 10.1111/liv.16075 – volume: 380 start-page: 1347 issue: 14 year: 2019 ident: 3946_CR17 publication-title: N Engl J Med doi: 10.1056/NEJMra1814259 – volume: 110 start-page: 777 issue: 2 year: 2024 ident: 3946_CR39 publication-title: Int J Surg – volume: 73 start-page: 202 issue: 1 year: 2020 ident: 3946_CR2 publication-title: J Hepatol doi: 10.1016/j.jhep.2020.03.039 – volume: 71 start-page: 835 issue: 3 year: 2020 ident: 3946_CR9 publication-title: Hepatology doi: 10.1002/hep.30864 – volume: 58 start-page: 1348 issue: 10 year: 2022 ident: 3946_CR37 publication-title: Medicina (Kaunas) doi: 10.3390/medicina58101348 – volume: 25 start-page: e44417 year: 2023 ident: 3946_CR41 publication-title: J Med Internet Res doi: 10.2196/44417 – volume: 16 start-page: 2063 issue: 13 year: 2024 ident: 3946_CR49 publication-title: Nutrients doi: 10.3390/nu16132063 – volume: 14 start-page: 12663 issue: 1 year: 2024 ident: 3946_CR12 publication-title: Sci Rep doi: 10.1038/s41598-024-63453-6 – volume: 160 start-page: 155999 year: 2024 ident: 3946_CR8 publication-title: Metabolism doi: 10.1016/j.metabol.2024.155999 – volume: 4 start-page: 1136 issue: 8 year: 2020 ident: 3946_CR47 publication-title: Hepatol Commun doi: 10.1002/hep4.1534 – volume: 23 start-page: 262 issue: 1 year: 2024 ident: 3946_CR29 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-024-02354-4 |
| SSID | ssj0017823 |
| Score | 2.4044442 |
| Snippet | Background
The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify... The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify the factors... Background The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify... BackgroundThe mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and identify... Abstract Background The mortality burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is rising, making it crucial to predict mortality and... |
| SourceID | doaj proquest gale pubmed crossref springer |
| SourceType | Open Website Aggregation Database Index Database Publisher |
| StartPage | 376 |
| SubjectTerms | Adult Aged Algorithms All-cause mortality Biomarkers Body mass index Cause of Death Cigarettes Complications and side effects Data mining Diabetes Diseases Fatty liver Fatty Liver - mortality Feature selection Female Forecasts and trends Gastroenterology Glucose Health aspects Hepatology Humans Hypertension Internal Medicine Kaplan-Meier Estimate Learning algorithms Liver diseases Longitudinal Studies Machine Learning Male Medical laboratories Medical research Medicine Medicine & Public Health Medicine, Experimental Metabolic diseases Metabolic dysfunction-associated fatty liver disease Metabolism Methods Middle Aged Missing data Mortality Non-alcoholic Fatty Liver Disease - mortality Nutrition Surveys Obesity Patient outcomes Prognosis Quality of life Risk Factors Statistics Survival Type 2 diabetes Ultrasonic imaging |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals (WRLC) dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yiHgRv62uEkHwoGHbfDSNt6fsspd9CCrsLaRNIgvddnntE_wz_I-dSdvnPkW8eCptpiXNzGRmmMlvCHnljQA_OpeM4wkZqYrA6io4pmsnnQ6ViVGmZhN6va7Oz83Ha62-sCZsggeeFu6oFvA55YME4ZJe8br0YNJV8Lr2wfN0dA-8niWYmvMHYPfEckSmKo8G2IU1FtsqlgsjSyb3zFBC6_9zT75mlH7Lkibjc3KX3Jm9RrqaZnuP3AjdfXLrbM6LPyA_zlJNZKBzE4ivFHxRerVBAqxrpq5tWeO2Q6CXyd8G35v2kV6GEYSgvWio_z6giUM2MTezLHga3QiULRZv0DmX84462vbY5mjrsaUWTQi1FM2hp31H16er9fGnh-TLyfHnD6dsbrbAGnCCRlbEGDHWqHMRjfeFExKcnxDKpmqEdgIxkHi694XXHLOfUkVjauNFzZsgHpGDru_CE0Ir7aKMPEhXeimVMU7xPMBV6ggsrDPyZll7ezVhatgUi1SlnThlgVM2ccrKjLxH9uwoEQ87PQApsbOU2H9JSUZeI3Mtau24cY2bDx_AhBH_yq4gzkVcnLLKyOEeJWhbsz-8iIedtX2wghelUojtl5GXu2F8EyvYutBvkSaXWpYQoWXk8SRWu1-S2IgYYsmMvF3k7NfH_74yT__Hyjwjt3nSC8UKdUgOxs02PCc3m2_jxbB5kbTqJ6nrJKU priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB5BFyEuvB-BBRkJiQNYm8R2EnNBXdTVXjZa8ZD2ZjmxvVop25QmReJn8I_xuG6XguDCKWoySd3OOzP-BuCVkczH0SmnOe6Q4SKztKmspmWjuS5tJZ3jYdhEWdfV2Zk8jS_chthWubGJwVCbvsV35AcszwohED_t_eIrxalRWF2NIzSuwx4ilfEJ7B3O6tOP2zqC939ss1WmKg4Gb41LbLoVNGWSF5TvuKOA2v-nbf7FOf1WLQ1O6OjO_y7_LtyO4SeZruXlHlyz8_tw8yQW2B_Aj5PQXGlJnCZxTnxQSxZLJMAGaaK7jrZ6NVhyGQJ3H8ST3pFLO3pp6i5aYr4P6CuR31RH3ltDnB49ZYddICQWhd4RTboe5yWtDM7mIgHqlqBfNaSfk_p4Ws8-PYQvR7PPH45pnNpAWx9NjTRzzmHS0qTMSWMyzbiPoqwt2qplpWYIppSHzyYzZY5lVC6clI00rMlbyx7BZN7P7RMgVakdd7nlujCcCym1yFPrj7x03IgmgTcb5qnFGpxDhaSmKtSa1cqzWgVWK57AIfJ3S4nA2uFEvzxXUU9Vw7z0CmO5t2X-K_KmMD6CFNaUjbEmlwm8RulQqP7jUrc67mLwC0YgLTX1CTMC7BRVAvs7lF5t293LG0FR0WwM6kpKEni5vYx3Yivc3PYrpEl5yQuf6iXweC2X25_EcaKxT0oTeLsR1KuH__2fefrvtTyDW3lQGUEzsQ-Tcbmyz-FG-228GJYvosr9BBwGM5E priority: 102 providerName: ProQuest |
| Title | Machine learning for predicting all-cause mortality of metabolic dysfunction-associated fatty liver disease: a longitudinal study based on NHANES |
| URI | https://link.springer.com/article/10.1186/s12876-025-03946-4 https://www.ncbi.nlm.nih.gov/pubmed/40375096 https://www.proquest.com/docview/3216558763 https://www.proquest.com/docview/3204746306 https://doaj.org/article/b3d935de44254d52b6d3925ed7bded29 |
| Volume | 25 |
| WOSCitedRecordID | wos001489564200006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LjtMw0GJ3EeLC-xFYKiMhcQCLJrbjmFsXdbUcWlW7gMrJcmJ7tVK3WTUpEp_BHzPjJoXyOMAlUeJx4tjzzIxnCHnhNAc9eihYhjtkhEw9KwtvmSqtsMoXOgQRi02o6bSYz_Ws2xTW9NHuvUsycupI1kX-pgFOqjBgVrIh1yJnYo8cgLgrkBxPzz5tfQcg83i_PeaP_XZEUMzU_zs__kkg_eIhjYLn-Pb_DfkOudUpmnS0wYy75Jpf3iM3Jp0r_T75NolhlJ52dSPOKaiv9GqFABgKTe1iwSq7bjy9jCo6qOu0DvTSt4A3i4uKuq8NSkVcWWa7VfaOBtsC5ALjPWjn_nlLLV3UWBlp7bAKF41JbSlKUEfrJZ2ejKbjswfk4_H4w7sT1tVnYBXoTS1LQwhonpRDHrRzqeUC9CXv86qouLIc0yZl8dqlTmXoMBUyaF1qx8us8vwh2V_WS_-Y0ELZIELmhc2dEFJrK7Ohh7NQQThZJuRVv2TmapOGw0TzpcjNZpYNzLKJs2xEQo5wVbeQmEI73qhX56ajSFNywFPpvACuBa_IytyBrii9U6XzLtMJeYk4YZDQ25WtbLdfAQaMKbPMCExjTKWTFwk53IEEAq12m3usMh2DaAzP0lxKTAeYkOfbZuyJQW9LX68RZiiUyMGoS8ijDTZuP0lg7WIwPxPyuke9Hw__-8w8-Tfwp-RmFrFXslQekv12tfbPyPXqS3vRrAZkT81VPBYDcnA0ns5OB_GfBlzN3k9mnweRML8DVIMugA |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4aHQJeuF8CA4wE4gGsNY6dCxJCBTa12lpVYkjjyTixPU3qmtKkoP0M_gi_ER836SgI3vbAU5XmNE3c79x6js8H8FRnkYuju5wy3CHDRWhonhpFk1xxlZg0s5Z7solkNEoPD7PxBvxo98JgW2VrE72h1mWB_5FvRyyMhcD5aW9mXyiyRmF1taXQWMJiz5x-cylb9Xrw3v2-zxjb3Tl416cNqwAtnLevaWitxaA670Y20zpUEXde3pi4SIsoUREO-2H-WIc6YVjm48JmWZ7pKGeFidx1L8Amd2BPO7A5HgzHn1Z1C-dvo3ZrThpvV876J9jkK2g3ynhM-Zr78ywBf_qCX5zhb9VZ7_R2r_1vy3UdrjbhNekt9eEGbJjpTbg0bBoIbsH3oW8eNaRhyzgiLmgnszkKYAM4UZMJLdSiMuTEJyYuSSGlJSemdtoyOS6IPq0wFkA8U9Vg22hiVe0kJ9jlQpqi1yuiyKREPqiFRu4x4kf5EowbNCmnZNTvjXY-3IaP57Igd6AzLafmHpA0UZZbZriKNeciy5RgXeNeeWK5FnkAL1qwyNly-Ij0SVsayyW0pIOW9NCSPIC3iKeVJA4O92-U8yPZ2CGZR047hTYIX_cVLI-1i5CF0UmujWZZAM8RjRLNWz1XhWp2abgbxkFhspdyLCancRrA1pqkM0vF-ukWmLIxi5U8Q2UAT1an8ZPY6jc15QJlujzhsUtlA7i71IPVI3FkbHZJdwAvW8U4u_jfV-b-v-_lMVzuHwz35f5gtPcArjCvroKGYgs69XxhHsLF4mt9XM0fNepO4PN5q8xPBn6QSA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BQRWX8oZAASMhcQCrSWwnMbcFuiqCrioVUG-WE9tVpTRZZbOV-Bn8YzxOdunyOCBOUeLJyx7PQzPzDcALI5m3o2NOU6yQ4SKxtCyspnmpuc5tIZ3jodlEPpsVJyfy6FIVf8h2X4Ukh5oGRGlq-r25ccMWL7K9hZeqOSbPChozyTPKr8I1jk2D0F8__rqOI3j9x1alMn-8b0MdBdT-32XzJeX0S7Q0KKHpzf___FuwMxqgZDJwzG24Yps7sH04htjvwvfDkF5pydhP4pR4s5bMOyTAFGmi65pWermw5DyY7t6MJ60j57b3_FSfVcR8W6C2xBWnelx9a4jTvaesMQ-EjGGhN0STusWOSUuD3blIALslqFkNaRsyO5jM9o_vwZfp_ud3B3Ts20Arb0_1NHHOodtSxsxJYxLNuLejrM2qomK5ZginlIZzk5g8xUAqF07KUhpWppVl92GraRv7EEiRa8ddarnODOdCSi3S2Pojzx03oozg1Wr51HyA51DBrSkyNcyy8rOswiwrHsFbXOE1JUJrhwttd6rGnapK5vlXGMu9NPOvSMvMeBtSWJOXxppURvAS-UOhAOg7XemxjsF_MEJpqYl3mRFiJysi2N2g9Bu32hxecZgaBcdCsTTJhECYwAier4fxTkyGa2y7RJqY5zzzzl4EDwbOXP8Sx57G3i2N4PWKDX8-_O8z8-jfyJ_B9tH7qfr0YfbxMdxIAyMLmohd2Oq7pX0C16uL_mzRPQ278QeQzTQ4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Machine+learning+for+predicting+all-cause+mortality+of+metabolic+dysfunction-associated+fatty+liver+disease%3A+a+longitudinal+study+based+on+NHANES&rft.jtitle=BMC+gastroenterology&rft.au=Wang%2C+Xueni&rft.au=Chen%2C+Huihui&rft.au=Wang%2C+Luqiao&rft.au=Sun%2C+Wenguang&rft.date=2025-05-15&rft.pub=BioMed+Central&rft.eissn=1471-230X&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs12876-025-03946-4&rft.externalDocID=10_1186_s12876_025_03946_4 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-230X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-230X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-230X&client=summon |